INTERLEUKIN-40 AS A PREDICTIVE TOOL OF RESPONSE TO TREATMENT FOR INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES. CMN. 2024;6(2):3635-3642. Accessed November 6, 2026. https://cahiersmagellanes.com/index.php/CMN/article/view/633